Skip to main content
AAN.com

Abstract

Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
2.
Katzman R. Alzheimer's disease. N Engl J Med 1986;314:964-973.
3.
Kokmen E, Beard CM, O'Brien PC, et al. Is the incidence of dementing illness changing? A 25-year-time-trend study in Rochester, MN(1960-1984). Neurology 1993;43:1887-1892.
4.
DeCarli C, Kaye JA, Horwitz B, Rapoport SI. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 1990;40:872-883.
5.
Squire LR, Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992;99:195-231.
6.
Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-1170.
7.
Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.
8.
Naidich TP, Daniels DL, Haughton VM, et al. Hippocampal formation and related structures of the limbic lobe: anatomic MR correlation. Part I. Surface features and coronal sections. Radiology 1987;162:747-754.
9.
Jack CR Jr, Gehring D, Sharbrough F, et al. Temporal lobe volume measurement from MR images: accuracy and left-right asymmetry in normal individuals. J Comput Assist Tomogr 1988;12(1):21-29.
10.
Jack CR Jr, Twomey CK, Zinsmeister AR, et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements for MR images in young adults. Radiology 1989;172:549-554.
11.
Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of hippocampal formation. Radiology 1990;175:423-429.
12.
Jack CR Jr, Bentley M, Twomey CK, Zinsmeister AR. MR-based volume measurements of the hippocampal formation and anterior temporal lobe: validation studies. Radiology 1990;176:205-209.
13.
Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991;41:51-54.
14.
Jack CR Jr, Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992;42:183-188.
15.
Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR Am J Neuroradiol 1994;15:927-937.
16.
Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J Neural Transm 1995;9:73-86.
17.
Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994;44:1660-1668.
18.
Pearlson G, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry 1992;49:402-408.
19.
Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol 1993;50:949-954.
20.
Convit A, deLeon MJ, Golomb J, George AE, et al. Hippocampal atrophy in early Alzheimer's disease: anatomic specificity and validation. Psychiatry Q 1993;64:371-387.
21.
Convit A, de Leon MH, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995;345:266.
22.
Petersen RC, Kokmen E, Tangalos EG, et al. Mayo Clinic Alzheimer's Disease Patient Registry. Aging 1990;2:408-415.
23.
Petersen RC, Smith G, Kokmen E, et al. Memory function in normal aging. Neurology 1992;42:396-401.
24.
Petersen RC, Smith GE, Ivnik RJ, et al. Memory function in very early Alzheimer's disease. Neurology 1994;867-872.
25.
Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. JAMA 1995;273:1274-1278.
26.
Ivnik RJ, Malec JF, Tangalos EG, et al. The Auditory-Verbal Learning Test (AVLT): norms for ages 55 years and older. Psychol Assess 1990;2:304-312.
27.
Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older Americans normative studies: WAIS-R, WMS-R, and AVLT norms for ages 56 through 97. Clin Neuropsychol 1992;6:1-103.
28.
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
29.
Jack CR Jr. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994;35(suppl 6):S21-S29.
30.
Duvernoy HM. The human hippocampus. An atlas of applied anatomy. Munich: JF Bergmann, 1988:77-91.
31.
Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology 1992;42:1743-1750.
32.
Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 1993;43:719-725.
33.
Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992;115:1001-1015.
34.
Adam C, Baulac M, Saint-Hilaire J, et al. Value of magnetic resonance imaging-based measurements of hippocampal formations in patients with partial epilepsy. Arch Neurol 1994;51:130-138.
35.
Free SL, Bergin PS, Fish DR, et al. Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol 1995;16:637-643.
36.
Kuks JBM, Cook MJ, Fish DR, Stevens JM, Shorvon SD. Hippocampal sclerosis in epilepsy and childhood febrile seizures. Lancet 1993;342:1391-1394.
37.
Murro AM, Park YD, King DW, et al. Seizure localization in temporal lobe epilepsy: a comparison of scalp-sphenoidal EEG and volumetric MRI. Neurology 1993;43:2531-2533.
38.
O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
39.
Mattis S. Mental status examination for organic mental syndromes in the elderly patient. In: Bellak KT, ed. Geriatric psychiatry. Grune and Stratton: New York, 1976.
40.
Folstein MF, Folstein SE, McHugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975;12:189-198.
41.
Gur RC, Mozley PD, Resnick SM, et al. Gender differences in age effect on brain atrophy measured by magnetic resonance imaging. Proc Natl Acad Sci USA 1991;88:2845-2849.
42.
Coffey CE, Wilkinson WE, Parashos IA, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992;42:527-536.
43.
Kaye JA, DeCarli C, Luxenberg JS, Rapoport SI. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography. J Am Geriatr Soc 1992;40:225-231.
44.
Dekaban AS, Sadowsky BS. Changes in brain weights during the span of human life: relation of brain weights to body heights and body weights. Ann Neurol 1978;4:345-356.
45.
Miller AKH, Alston RL, Corsellis JAN. Variation with age in the volumes of grey and white matter in the cerebral hemispheres of man: measurements with an image analyser. Neuropathol Appl Neurobiol 1980;6:119-132.
46.
Zatz LM, Jernigan TL, Ahumada AJ. Changes on computed cranial tomography with aging. Intracranial fluid volume. AJNR Am J Neuroradiol 1982;3:1-11.
47.
Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol Aging 1995;16:591-606.
48.
DeCarli C, Murphy DGM, Gillette JA, et al. Lack of age-related differences in temporal lobe volume of very healthy adults. AJNR Am J Neuroradiol 1994;15:689-696.
49.
Murphy DGM, DeCarli C, Schapiro MB, et al. Age-related differences in volumes of subcortical nuclei, brain matter, and cerebrospinal fluid in healthy men as measured with magnetic resonance imaging. Arch Neurol 1992;49:839-845.
50.
Salerno JA, Murphy DGM, Horwitz B, et al. Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. Hypertension 1992;20:340-348.
51.
Chang F-LF, Parisi JE, Jack CRJ, Petersen RC. Morphometric analysis of the hippocampus in Alzheimer's disease: post-mortem MRI and histological correlates. Ann Neurol 1992;32:268.
52.
Rosene DL, Van Hoesen GW. Hippocampal efferents reach widespread areas of cerebral cortex and amygdala in the rhesus monkey. Science 1977;198:315-317.
53.
Van Hoesen GW, Pawdya DN, Butters N. Cortical afferents to the entorhinal cortex of the rhesus monkey. Science 1972;175:1471-1473.
54.
Witter MP, Room P, Goenewegen HJ, Lohman AHM. Connections of the parahippocampal cortex in the cat. V. Intrinsic connections; comments on input/output connections with the hippocampus. J Comp Neurol 1986;252:78-94.
55.
DeCarli C, Murphy DGM, McIntosh AR. Discriminant analysis of Alzheimer's disease. Arch Neurol 1994;51:1088-1089.
56.
DeCarli C, Murphy DGM, McIntosh AR, et al. Discriminant analysis of MRI measures as a method to determine the presence of dementia of the Alzheimer type. Psychiatry Res 1995;57(2):119-130.
57.
Laakso MP, Partanen K, Lehtovirta M, et al. MRI of amygdala fails to diagnose early Alzheimer's disease. Neuroreport 1995;6:2414-2418.
58.
Laakso MP, Partanen K, Riekkinen P, et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678-681.

Information & Authors

Information

Published In

Neurology®
Volume 49Number 3September 1997
Pages: 786-794
PubMed: 9305341

Publication History

Published online: September 1, 1997
Published in print: September 1997

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Clifford R. Jack, Jr, MD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Ronald C. Petersen, PhD, MD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Yue Cheng Xu, MD, PhD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Stephen C. Waring, DVM, PhD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Peter C. O'Brien, PhD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Eric G. Tangalos, MD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Glenn E. Smith, PhD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Robert J. Ivnik, PhD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.
Emre Kokmen, MD
From the Departments of Diagnostic Radiology (Drs. Jack and Xu), Neurology(Drs. Petersen and Kokmen), Health Sciences Research (Drs. Waring, O'Brien, and Petersen), Internal Medicine (Dr. Tangalos), Department of Psychiatry and Psychology (Drs. Smith and Ivnik), Mayo Clinic and Foundation, Rochester, MN.

Notes

Address correspondence and reprint requests to Dr. Clifford R. Jack, Jr., Mayo Clinic, Diagnostic Radiology, 200 First Street SW, Rochester, MN 55905.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Paying Homage to Microvessel Remodeling and Small Vessel Disease in Neurodegeneration: Implications for the Development of Late-Onset Alzheimer’s Disease, Journal of Vascular Diseases, 3, 4, (419-452), (2024).https://doi.org/10.3390/jvd3040033
    Crossref
  2. Mild Cognitive Impairment Progression and Alzheimer’s Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months, Journal of Clinical Medicine, 13, 2, (518), (2024).https://doi.org/10.3390/jcm13020518
    Crossref
  3. Hemispheric asymmetries in hippocampal volume related to memory in left and right temporal variants of frontotemporal degeneration, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1374827
    Crossref
  4. Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity, Frontiers in Aging Neuroscience, 16, (2024).https://doi.org/10.3389/fnagi.2024.1428244
    Crossref
  5. TDP-43 Is Associated with Subiculum and Cornu Ammonis 1 Hippocampal Subfield Atrophy in Primary Age-Related Tauopathy, Journal of Alzheimer’s Disease, 99, 3, (1023-1032), (2024).https://doi.org/10.3233/JAD-240136
    Crossref
  6. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer’s Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition, Journal of Alzheimer's Disease, 99, 1, (279-290), (2024).https://doi.org/10.3233/JAD-231131
    Crossref
  7. Machine Learning-Derived MRI-Based Neurodegeneration Biomarker for Alzheimer’s Disease: A Multi-Database Validation Study, Journal of Alzheimer's Disease, 97, 2, (883-893), (2024).https://doi.org/10.3233/JAD-230574
    Crossref
  8. Possibilities and prospects of the MR morphometry method in the diagnosis of dementia, Meditsinskiy sovet = Medical Council, 12, (22-30), (2024).https://doi.org/10.21518/ms2024-289
    Crossref
  9. Chapter 7. Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?, Diagnostic Issues in Dementia: Advancing the Research Agenda for DSM-V, (99-115), (2024).https://doi.org/10.1176/appi.books.9780890427682.lg07
    Crossref
  10. Chapter 25. Use of Biomarkers in the Elderly: Current and Future Challenges, Age and Gender Considerations in Psychiatric Diagnosis: A Research Agenda For DSM-V, (317-328), (2024).https://doi.org/10.1176/appi.books.9780890427668.lg25
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share